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Objective: to compare electronic and manual prescriptions of a public hospital of Brasilia, 
identifying risk factors for the occurrence of medication errors. Method: descriptive-exploratory, 
comparative and retrospective study. Data collection occurred from July 2012 to January 2013, 
using an instrument for the review of the information contained in medical records related to the 
medication process. A total of 190 manual and 199 electronic records composed the sample, with 
2027 prescriptions each. Results: compared to the manual prescription, a significant reduction 
was observed in the risk factors after implantation of the electronic prescription, in items such 
as “lack of the form of dilution” (71.1% to 22.3%) and “prescription with brand name” (99.5% 
to 31.5%). Conversely, the risk factors “no check” and “lack of CRM of the prescriber” increased. 
The lack of the allergy registration and the occurrences related to medication were the same for 
both groups. Conclusion: generally, the use of the electronic prescription system was associated 
with a significant reduction in risk factors for medication errors, concerning the following aspects: 
illegibility, prescription with brand name and presence of essential items that provide a safe and 
effective prescription.
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Introduction
The identification of risk factors for errors related 
to medication administration has proved important 
to ensure greater safety for patients and health 
professionals. They can be identified, for example, by 
analyzing medical prescriptions, which allows preventive 
actions to reduce the occurrence of adverse events. 
In the literature it can be verified that the electronic 
prescription (EP) system for medications has enabled 
higher quality care to hospitalized patients and others 
involved, demonstrating that the choice of this model 
can help to reduce errors related to medications by up 
to 50%(1-2). Other studies also refer to improvements 
in antibiotic prescriptions and reduced time and cost of 
hospitalization(3-4). However, there are publications that 
indicate increased mortality after its implementation(5-7), 
medical team resistance in the use of electronic 
prescription due to time constraints, impairments in the 
interaction between patients and nurses, and lack of 
integration with the flow work(8).
These data are worrying, because events of 
this nature are frequent and constitute a concern for 
healthcare professionals, patients, and government 
agencies. Accordingly, the Ministry of Health and the 
National Health Surveillance Agency (Anvisa) launched, 
in April 2013, the National Patient Safety Program, with 
the focus on preventing and reducing the incidence of 
situations that result in harm to patients.
Internationally, the issue has also been the subject 
of various investigations. Studies have shown that, 
after the implementation of the electronic prescription 
system, there has been a reduction in the frequency of 
medication errors(1-2,7,9). In Brazil, however, this strategy 
has still been little investigated. Among the few studies, 
one investigated the presence of prescriptions smudged 
after printing (18%), suspended medications (17%) and 
lack of information about presentation, time (9%) and 
route of administration (82%)(10).
International studies that comparatively investigated 
manual and electronic prescriptions(11-13), showed a 
reduction in prescribing error rates and improved 
outcomes for patients following the implementation of 
an electronic system. Given the above, knowing the 
prescription system and its functionality is essential 
for a safety proposal for both patients and health 
professionals. 
With regard to the administration of medication, 
to talk about safety necessarily refers to reducing the 
risk of errors that generally occur in the prescription, 
dispensing and administration stages. Studies show 
that: 72% of them started with the prescription and 
15% during the administration(14). In a study conducted 
recently in Brasilia, Brazil, with a total of 484 doses 
observed, errors occurred during the administration of 
the drug in 69.5% of them: 69.6% during the preparation 
phase, 48.6% were time errors, 1.7% dosage errors and 
9.5% derived from omission(15).
Despite some advantages, one of the difficulties 
in the adoption of EP may be the high cost of the 
system, as well as a high risk that its implementation is 
ineffective and may produce unintended consequences 
and harm(4,16). In Brazil, various institutions have already 
adopted this system, however, it is still necessary 
to know how its implementation is going and how 
professionals interact with it. It is also fundamental to 
investigate whether it is, in fact, providing greater safety 
and quality for the care. 
Considering the potential benefits of the electronic 
prescription and how the computerized system 
contributes to reducing medication errors, reducing 
costs and assuring the quality of care provided, it was 
proposed to investigate these aspects in a hospital of 
the city of Brasilia.
Accordingly, this study aimed to compare electronic 
(EP) and manual prescriptions (MP) of a public hospital 
of Brasilia, identifying risk factors for the occurrence of 
medication errors.
Method
This was an exploratory, descriptive and comparative 
study, performed in the internal medicine department of 
a public hospital of Brasilia, the Federal District, Central 
Region of Brazil. The clinic has 31 beds reserved for 
patients with chronic and degenerative diseases with 
long periods of hospitalization, which, because of the 
treatment, make use of various medications.
It should be noted that in this unit the electronic 
prescription system was implemented in August 2011. 
The electronic patient record (EPR) presents the 
following information: prescription of the medication, 
request for and results of examinations, notes of nursing 
professionals, medical evolution and requests for 
materials and medications. It also contains support for 
the clinical decision, making the prescription safer and 
more efficient, namely: allergy alerts, duplicate checking 
and dose and body mass index (BMI) calculation.
The medical records of patients, aged over 18 
years, hospitalized in the internal medicine department, 
from July 2010 to September 2012, were included. The 
records not drawn were excluded. The constitution of EP 
and MP samples was defined by convenience through 
simple drawing, in order to ensure the inclusion of 
records that represent admissions for every month of 
the data collection period. Per month, on average 15 to 
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17 patients were drawn and included in the analysis list, 
with the others being excluded. In the event that any 
of the randomly selected patients were not found, the 
records of another, in the same month, was drawn.
The MP sample was calculated based on admissions/
year in the internal medicine department, this being 
456, with an average of 38 per month. Thus, for the 
calculation of the sample, N= 456, corresponding to the 
total admissions for the period July 2010 to July 2011, 
213 medical records were included to be reviewed, 
considering a 0.05 confidence level and sampling error 
of 4%. 
Due to the difficulty of access to the manual 
patient records after implementation of the electronic 
system, a sample of 190 patient record manuscripts was 
analyzed, totaling 2, 027 manual prescriptions (MP), 
which constituted the MP group. For this collection, 
the researchers drew up a list of the patient records to 
be analyzed, which were separated by the medical file 
sector team and made available to the researchers.
With regard to the EP, total admissions in the 
internal medicine department from September 2011 to 
September 2012 were 415. The same sample calculation 
method was used, giving the number of 200 patient 
records to be reviewed. As one of the patients had two 
registration numbers in the system, in the end 199 
electronic medical records were analyzed, with a total of 
2,027 electronic prescriptions. 
At this time, the patient records were reviewed 
directly on the computer, after digitizing the patient 
record drawn and generating the EPR as a PDF.
Data collection was supported by two trained 
nurses, with retrospective analysis carried out of the 
information contained in the 4054 prescriptions selected.
The data collected were recorded in a specific 
instrument, called the Instrument Used in the Review 
of Patient Records Related to the Medication Process, 
previously tested and adapted from earlier studies(17). 
The dependent variables analyzed at this stage 
were: manual prescriptions (handwritten); electronic 
prescriptions, performed on the computer and typed into 
the electronic prescription system. In order to achieve 
the purpose of assessing the presence or absence 
of information related to medications in the medical 
developments and outcomes and nursing notes, these 
were also analyzed in the medical records included in 
the sample.
The independent variables were diverse, namely: 
illegible handwriting, when it was impossible to 
understand what was written or when at least one item 
was indecipherable; and legible handwriting, when it 
was possible to read without difficulty, problems, or 
spending time trying to understand what was written, 
which included all the words, numbers, symbols and 
abbreviations. The absence of the following information 
was also noted: bed number, registration number, name 
and CRM of the prescriber, date, registration of allergies, 
date and time updated, and the lack of data on the 
presentation of the drug, the route of administration, 
the form of dilution, the frequency of administration and 
prescribed medication with brand name. Inappropriate 
acronyms and abbreviations were considered inadequate, 
especially abbreviations of drug names, such as HCTZ 
(hydrochlorothiazide). Further independent variables 
were: erasures (scratches, smudges, deletion of letters 
or words of the prescription), scraped or scratched, 
and changes/suspensions: presence of changes in the 
prescription throughout the day, change or suspension 
of the medication or of the care: incomplete time 
designations, with errors/erasures were also analyzed: 
lack of information on the medication administration 
schedule or erasures of the appointed time: medications 
without checking: lack of registration of the medication 
administration, the word OK or the symbol “P” 
corresponding to the administration at the time that 
the drug was prescribed: lack of justification for not 
checking: absence of record of justification of the type 
“does not have in the pharmacy”, “missing”, “verbally 
suspended by the physician”, in the prescription itself 
or the outcomes/nursing notes: presence or absence 
of observations and suspension of medications in the 
medical or nursing outcomes: and lack of informative 
record. Finally, the presence or absence of registration 
of the administration of SOS medications was analyzed 
in the nursing outcome: SOS medication “if necessary” 
and “if the need arises”. 
The Statistical Package for the Social Sciences 
(SPSS ® v. 18. 0) was used to organize and process the 
data. The categorical variables are reported as absolute 
and relative frequencies and the numerical variables as 
mean and standard deviation (minimum and maximum).
All variables were analyzed using univariate and 
multivariate analyses, considering a significance level of 
5%. The odds ratio (OR) was calculated, with confidence 
intervals (CI) of 95% and, for associations, the chi-
square and Mann-Whitney tests were used.
The development of the study complied with the 
national and international standards of ethics in research 
involving human subjects, with authorization, under 
number 017/2012, from the Research Ethics Committee 
of the Federal District Health Department.
Results
Table 1 presents the distribution of the manual 
(MP) and electronic prescriptions (EP).
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Table 1 - Distribution of medical prescriptions according to handwriting, lack of essential items of the prescription, 
erasures, scheduling and medications without checking. Brasilia, DF, Brazil, 2013
Medical prescription information Manual n* (%) Electronic *n (%) P value† OR
‡ gross
(CI§ 95%)
Handwriting
Legible 1408(69.5) 2027(100.0)
Illegible 88(4.3) -
Partly|| 531(26.2) -
Lack
Bed number 1746(86.1) 1931(95.3) <0.000 1.57(1.46-1.68)
Registration number 512(25.3) 204 (10.8) <0.000 3.02 (2.53-3.60)
Name and CRM¶ of prescriber 24(1.7) 1411(98.3) <0.000 45.72(30.73-68.03)
Date 42 (2.1) 4(0.2) <0.000 10.70 (3.83-29.89)
Allergies registration 2009(99.1) 1919 (94.7) 0.042 1.13 (1.01-1.27)
Date and time updated 102 (41.6) 330 (16.3) <0.000 4.74 (4.10-5.49)
Justification 1635(80.7) 1865 (92.0) <0.000 1.51 (1.42-1.61)
Presence
Erasures 458 (22.6) - - -
Changes or suspensions 685 (33.8) 1230 (11.3) <0.000 1.75(1.65-1.85)
Incomplete schedule 204 (10.1) 64 (3.2) <0.000 3.43(2.57-4.57)
Schedule with error or erasures 293(14.5) 55(2.7) <0.000 6.05(4.51-8.13)
Medications without checking** 631(31.1) 1605(79.2) <0.000 8.41(7.29-9.70)
* n=2027.
† p value.
‡ OR Odds Ratio.
§ Confidence Interval 
║ Partly. Prescriptions in which it was impossible to completely read all the medications and care prescribed.
¶ Regional Council of Medicine;
** record of performing the procedure in the medical prescription.
Starting from the premise that illegibility increases 
the risk of medication errors, it was observed that the 
EP eliminated the occurrence of illegible prescriptions 
and erasures, which constitutes a major benefit of the 
system.
 Risk factors related to the lack of date and time 
updated, registration number and occurrence of 
allergies were also reduced with the implementation of 
the electronic system. It was observed that the absence 
of such information in the MP is significantly greater 
than in the EP. 
The factor name and CRM of the prescriber was 
absent in 98.3% of the EP. Importantly, in the case 
of electronic prescriptions, a password is required 
to access the system that enables the prescriber to 
issue prescriptions and make changes; however, the 
registration data are not recorded in the electronic 
medical record, which explains the error of absence of 
prescriber identification information (CRM) in the EP 
being 45.72 times higher than in the MP. 
The lack of bed number and the absence of 
justification for not administering the medication also 
represented the risk factors most present in the EP. 
Accordingly, adaptations to the electronic system could 
easily resolve the matter, contributing to the prevention 
of errors and increasing patient safety. 
The variables, presence of alterations or 
suspensions were reduced in the EP, configuring another 
factor that favors safety, since the lower the number of 
modifications, the lower the risk of errors.
At first, the schedule is set by the nurse and the 
system maintains it until someone changes it. However, 
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a probability of errors was often verified due to, for 
example, duplicated therapies with the use of two 
medications for the same purpose, scheduled for the 
same time, as well as medication interactions. As the 
system has the support for the clinical decision resource, 
there is the possibility of easily eliminating errors of this 
nature if all the resources are used. However, even with 
this weakness, the risk of the presence of scheduling 
with error/erasures in the MP was still 6.05 times higher 
than in the EP. 
With regard to incomplete scheduling, there was a 
3.43 times greater chance of this being present in the 
MP than in the EP. Therefore, there was a significant 
increase of these variables in the electronic prescription, 
demonstrating another of its benefits. Medications 
administered without checking, also presented in Table 
1, is another worrying factor, as this increased from 
31.1% in the MP to 79.2% in the EP, constituting an 
8.41 times higher risk.
The absence of justification for not carrying out the 
checks also increased in the EP, which is attributed to 
the ease of noting the reason for not checking in the MP. 
Furthermore, the fact can also be associated with the 
distance of the computers from the bed of the patient, 
which increases the chance of forgetting to record this 
information, or with the lack of ability of professionals 
with the electronic system, so that the check is often 
performed incorrectly. 
The following constitute factors that did not 
contribute to the prevention of medication errors: 
“presence of medication without checking” and “lack of 
justification for not administering the medication”. 
Table 2 shows the information of the medical 
prescriptions according to the lack of presentation, route, 
dilution, frequency, presence of prescription with brand 
name and inappropriate acronyms and abbreviations.
Table 2 - Distribution of the medical prescriptions according to the lack of presentation, route, dilution, frequency, 
presence of prescription with brand name and inappropriate acronyms and abbreviations. Brasilia, FD, Brazil, 2013
Essential information on the medical 
prescription
Manual
n* (%) Electronic n
* (%) P value† OR
‡ gross
(CI§ 95%)
Illegible 88(4.3) -   
Lack     
Form of presentation 213(10.5) 41(2.0) <0.000 5.68(4.07-7.99)
Route 19 (0.9) 8(0.4) 0.051 2.38(1.04-5.46)
Form of dilution 1442(71.1) 453(22.3) <0.000 8.56(7.43-9.87)
Frequency 51(2.5) 6(0.3) <0.000 8.69(3.72-20.30)
Prescribed medications with brand name 2016(99.5) 639(31.5) <0.000 96.57(53.58-174.0)
Inappropriate acronyms and abbreviations 2022(99.8) 1767(87.2) <0.000 28.28(11.86-67.42)
* n=2027.
† p-value.
‡ OR Odds Ratio.
§ Confidence Interval 
Regarding the risk factors “lack of form of 
dilution”, “lack of route”, “lack of frequency” and “lack 
of presentation”, there was a reduction in all. The 
possibility of data not being present on frequency, form 
of dilution, presentation of the medication and route of 
administration in the MP was significantly higher than 
in EP. Regarding this aspect, the implementation of EP 
enabled a safer prescription (p<0.000) (Table 2). 
The risk of prescriptions being issued with the brand- 
was higher name in the MP than in the EP (p<0.000). 
Inappropriate acronyms and abbreviations were found 
in 100% of the prescriptions, and in the medical and 
nursing outcomes. Often, abbreviations or acronyms are 
used in order to save time, however, this is a risk factor, 
since they may be erroneously interpreted by health 
professionals. 
When used, abbreviations should follow 
standardization to facilitate their understanding. 
However, at the study site, an absence of standard 
abbreviations and acronyms was observed. The risk of 
using abbreviations was higher in the MP than in the EP.
According to Table 2, all the risk factors analyzed 
were enhanced with the electronic system, especially 
concerning acronyms and abbreviations.
Table 3, below, provides information about 
medications found in the medical and nursing outcomes.
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Table 3 - Distribution of information about medications in the medical and nursing outcomes. Brasilia, FD, Brazil, 2013
Information about medication in the outcomes Manual n* (%) Electronic *n (%) P value† OR
‡ gross
(CI§ 95%)
Observations in the medical outcomes 326(16.1) 1114(55.0) <0.000 6.36(5.49-7.37)
No 1701(83.9) 913(45.0)
Suspension in the medical outcomes 123(6.1) 102(5.0) 0.085 1.09(0.97-1.24)
No 1904(93.9) 1925(95.0)
Prescription in the medical outcomes 448(22.1) 411(20.3) 0.083 1.05(0.98-1.13)
No 1579(77.9) 1616(79.7)
Observations in the nursing outcomes 340 (16.8) 533(26.3) <0.000 1.77(1.51-2.06)
No 1687(83.2) 1494(73.7)
SOS Medications|| in the nursing outcomes 135(6.7) 184(9.1) 0.003 1.39(1.11-1.76)
No 1892(93.3) 1843(90.9)
* n=2027.
† p value.
‡ OR Odds Ratio.
§ Confidence Interval 
||SOS= medications “if necessary” or “in case of necessity”.
The registration of complications and/or 
observations about medications in the medical and 
nursing outcomes represents another source, in 
addition to the prescription, to obtain information. This 
variable can affect patient safety in the medication 
process.
It appears that after the implementation of 
electronic medical records at the hospital where 
this study was conducted, there was an increase of 
observations relating to medications in the medical 
and nursing outcomes. Medical records regarding 
the medications also became more frequent with the 
electronic medical record. The risk of occurrence of 
drug information in the medical outcomes in the EP was 
6.36 times that that in MP (p<0.000), as well as in the 
nursing outcome. The registration of SOS medications in 
the EP was greater than in the MP. It was verified that 
computerization favors the records of the medical and 
nursing staff professionals. 
Discussion
Medication errors can cause major health problems, 
with relevant economic and social repercussions that, in 
a certain way, directly affect the lives of patients and the 
health professionals and institution, as well as prolong 
the hospitalization period and affect the treatment(1-2,4).
The EP is one of the main measures to prevent 
medication errors(18). Studies have shown the 
possibility of a significant reduction of serious errors 
by implementing this system, with advanced support 
for the clinical decision. Accordingly, the results of this 
study converge with those of other investigations with 
regard to improving patient safety and reducing risk 
factors for such situations(19-21).
The systems that support clinical decision are 
more complete and offer suggestions as to the route 
of administration and any correction in the drug dose 
and frequency values. In addition, other more complex 
systems cover checks for allergies, laboratory test 
results, drug interactions and provide clinical protocols 
to support the prescriber(21-22). 
These tools can also improve the process for safer 
medication administration, using technology, such as 
smart infusion pumps, computers at the bedside and 
medication administration system with barcodes. 
In particular, computers at the bedside, in 
association with the computerization of the system, 
make the registration faster, reducing the time spent 
completing documentation by 30% and reducing 
potential faults(22). The use of bar codes reduces the 
occurrence of errors by 93% and ensures high-conformity 
between what is prescribed and what is administered, 
also allowing the integration of the electronic system in 
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observed in the adjusted probability of errors that did 
not cause harm(20). 
As in other studies, the benefits of the electronic 
prescription observed in this study are linked to the fact 
that it is a technology used to facilitate and ensure the 
safest prescription of the medications(21). However, if it is 
not used properly, it can not achieve these goals. Thus, 
it is understood that the electronic prescription, by itself, 
does not eliminate the possibility of medication errors. 
Among its disadvantages, it is worth mentioning 
that this is a complex project that is still expensive, 
which restricts the number institutions that can adopt 
it, even in the USA(3). Some faults observed in the 
system can configure another disadvantage: Repetition 
of prescriptions from previous days, without review, and 
information entered incorrectly(10). These practices can 
negatively affect the safety of the medication process 
and therefore require intervention(21). 
Finally, the risk factor of erasures should be 
highlighted, which is reduced with the EP, thus providing 
more security to the medication process. In agreement 
with other studies(10,21), the lack of registration of the 
nursing team regarding administration of the medication 
was another problem identified in this study, which, 
even with the implementation of EP, has not been 
solved. Failure to check medications is something usual, 
however, it is believed that with adjustments to the 
system its occurrence can be reduced.
Limitations in the present study are related to the 
use of secondary data and difficulty of access to the 
patient record manuscripts. The study analyzed the 
prescriptions generated by the electronic system and did 
not include the analysis of its structure and functionality 
or of its acceptance and the interaction of professionals 
with the system. 
Conclusion
The implementation of a electronic prescription 
system is associated with a reduction of risk factors for 
medication errors. Elimination of illegibility is an inherent 
aspect of the electronic prescription process, which 
also minimizes the use of inappropriate abbreviations, 
erasures and lack of information. The improved risk 
factors (n=9) with the implementation of the EP relate 
to the scheduling, changes/suspensions, handwriting, 
erasures, date and time updated, registration number 
and allergies registration. The factors that were worse 
(n=4) with the EP were: presence of medications 
the handling of utensils. Smart infusion pumps, present 
in 41% of American hospitals, show good results in the 
reduction of medication errors, by means of audiovisual 
alerts when presented with incorrect orders, inadequate 
dose calculations or programming errors(23).
The results of this study demonstrate that the 
illegibility risk factor is virtually eliminated with EP, similar 
to that found in other national and international studies, 
which showed(24) 4% of illegible prescriptions(9,21,25). It 
should be noted that prescriptions that are difficult to 
understand hinder the practice of nurses and technicians 
and enhance the risk of errors, thus compromising 
patient safety. In this context, the EP ensures legibility 
and integrity of prescription fields, reducing transcription 
errors and facilitating the tracking of the prescriptions. 
Furthermore, when the system provides support for the 
clinical decision, it can improve the prescription and give 
more transparency to the communication process and 
reliability for the contents. 
The EP also contributed to the presence of essential 
information for the prescription (route, dilution, 
frequency), in that the absence of such data can cause 
problems at the time of preparation, dispensing and 
administration of the medication for the patient. To 
provide all the elements of information is, therefore, 
essential for a safe prescription.
Other studies show incomplete or inaccurate 
information as one of the main causes of medication 
errors, as well as the absence of data on the date and 
route(10).
To enter the name of the active ingredient is a 
procedure considered obligatory by law in the public 
services of Brazil (Law No. 9. 787, of February 10, 
1999), determining that, in these spaces, it is obligatory 
to prescribe the medications by the generic name. This 
is a procedure for reducing the exchange of names of 
similar drugs, as the brand names change from one 
geographic region to another. Traditionally, the use of 
the brand name was used in the MP, which can lead 
to errors. Now, with the introduction of the electronic 
prescription, this possibility has been reduced, since the 
name of the active ingredient is used(10,21).
A study comparing manual and electronic 
prescriptions showed that the frequency of errors 
decreased from 18.2% with the MP to 8.2% with the 
EP. The greatest reductions were seen in adjusted 
probabilities of errors regarding illegibility (97%), the 
use of inappropriate abbreviations (94%) and the lack of 
information (85%). In this study, a 57% reduction was 
www.eerp.usp.br/rlae
8 Rev. Latino-Am. Enfermagem 2016;24:e2742
without checking, justifications for not administering, 
name and CRM of the physician and bed number, 
although these are considered easy to resolve with 
system changes. 
Studies of this type contribute to the 
development of incentive policies for patient safety 
and investments in this area, as well as preserving the 
health professionals and protecting the patients. The 
contributions of the study results are applicable to 
the context of the institution field of study, especially 
for the improvement of electronic prescription 
practices with regard to the reduction of risk factors 
for medication errors. 
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